Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Hawaii for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Hawaii only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Hawaii (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Deryll Ambrocio (NPI 1730301219)

Field	Value
Entity Type	Individual
Organization	Deryll Ambrocio
Address	1329 Lusitana St
City	Honolulu
State	HI
ZIP	96813
Taxonomy	Rheumatology Physician
NPI Enumerated	May 3, 2007

Payer Source	Total Paid
Medicare	$666.3K
Medicaid	$0

Key Findings

DERYLL AMBROCIO’s Medicare billing is heavily focused on high-volume injectable biologics and a smaller volume of office E/M visits. The top revenue drivers are J3111, J0897, and 99214, with J3111 generating $446.9K (66.6% of Medicare revenue), J0897 $165.2K (24.6%), and 99214 $34.8K (5.2%); the provider’s precomputed top-3 Medicare codes account for 96.4% of total Medicare revenue. These code-level revenues and descriptions point to a practice model centered on in-office administration of specialty bone therapies (romosozumab and denosumab) supplemented by moderate-complexity established patient visits.

Revenue concentration is extreme: the three listed codes make up 96.4% of this provider’s Medicare revenue, leaving only a small residual across many other codes. That concentration implies the provider’s Medicare financial performance is highly dependent on continued administration of J3111 and J0897 rather than diversified E/M or procedural revenue streams.

Operational profile: drug-administration activity dominates claim volume and unit payments. J3111 shows 55.9K claims at $8 avg paid/claim and J0897 shows 9.2K claims at $18 avg paid/claim, while 99214 has 363 claims at $96 avg paid/claim; this mix — many low-dollar drug claims plus fewer higher-paid office visits — is consistent with an infusion/injection-focused service line delivering frequent biologic doses. The presence of 96372 (478 claims, $12 avg paid/claim) further supports an in-office injection administration workflow, and 96372 is described as notably above typical national volume for this code.

Competitive standing on Medicare is relatively strong for the primary biologic codes but not dominant across all providers. J3111 ranks #56 of 970 providers nationally (94th percentile) but is characterized in the data as typical, unremarkable volume for this code; J0897 ranks #1308 of 10057 (87th percentile) and is also labeled typical, unremarkable volume for this code. The established-visit code 99214 ranks #79127 of 479517 (83th percentile) and likewise carries the label typical, unremarkable volume for this code, indicating respectable but not outlier market positions for core services.

A clear statistical outlier in utilization is the injection administration code 96372, which ranks #1776 of 58224 providers nationally (97th percentile) and is explicitly noted as notably above typical national volume for this code. That elevated administration count suggests this provider performs injections at a higher-than-typical rate relative to peers, consistent with the heavy J3111 and J0897 throughput.

Payer mix is effectively single-payer Medicare: lifetime Medicare revenue is $666.3K while Medicaid billing is listed as none on file. This absence of Medicaid activity means analyses of Medicaid contracting, managed care exposure, or state-program risk are not applicable for this provider based on available claims.

Provider tenure is long-standing: the NPI was enumerated on 2007-05-03 (~19 years ago), indicating an established presence in the market. That duration supports the interpretation that the current code mix reflects a stable, practiced service line rather than a short-term billing anomaly.

Lower-revenue CPTs and procedures appear ancillary to the core drug-administration business. Examples include 20610 (72 claims, $39 avg paid/claim, $2.8K revenue) and J1040 (65 claims, $9 avg paid/claim, $585 revenue), both described as typical, unremarkable volume for their codes; these items likely represent episodic joint injections or steroid administrations that complement but do not materially drive overall revenue.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

9 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J3111	Injection, romosozumab-aqqg, 1 mg	55,860	$10	$446.9K
J0897	Injection, denosumab, 1 mg	9,180	$20	$165.2K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	360	$100	$34.8K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	160	$70	$10.3K
96372	A therapeutic, prophylactic, or diagnostic substance (a fluid, a drug, etc.) is injected via intramuscular or subcutaneous route into the patient's body. The procedure is performed by the physician…	480	$10	$5.7K
99204	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider…	20	$130	$2.8K
20610	In this procedure, the provider inserts a needle through the skin of a patient and into a major joint or bursa and then uses the syringe attachment to the needle to remove fluid or he may inject a…	70	$40	$2.8K
99205	The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider…	10	$150	$1.9K
J1040	Injection, methylprednisolone acetate, 80 mg	70	$10	$590

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 9 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Hawaii Distribution

Deryll Ambrocio — 2 of 9 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Hawaii

Full comparison — all codes billed, vs. state median

9 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J3111	1	10	33,920	$10	$262.5K
J0897	5	20	2,530	$20	$121.5K
99214	215	1,440	100	$80	$15.2K
99213	411	1,460	70	$60	$8.4K
99204	414	630	30	$110	$5.3K
99205	168	200	20	$160	$5.1K
20610	23	60	50	$50	$3.6K
J1040	3	10	70	$10	$820
96372	3	160	40	$10	$780

Related Providers

Other providers that share a Tax Identification Number (TIN) with Deryll Ambrocio, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Deryll U Ambrocio Md Incorporated	HI	Rheumatology Physician	$0	$100.1K

Nearby Providers

Other providers in the same ZIP code as Deryll Ambrocio, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
The Queens Medical Center	HI	General Acute Care Hospital	$0	$200M
Straub Clinic & Hospital	HI	General Acute Care Hospital	$0	$45.6M
State Of Hawaii Dept. Of Health Adult Mental Health Division	HI	Community/Behavioral Health Agency	$0	$29.3M
Positive Behavior Supports Corporation	HI	Community/Behavioral Health Agency	$0	$26.4M
Easter Seals Hawaii	HI	Developmentally Disabled Services Day Training Agency	$0	$16.8M
The Emergency Group, Inc.	HI	Emergency Medicine Physician	$0	$15M
Hawaii Dental Group, Inc.	HI	General Practice Dentistry	$0	$12.4M
The Queen's Medical Center	HI	General Acute Care Hospital	$0	$10.3M
Hawaii Home Care Inc	HI	Nursing Care Agency	$0	$9.3M
Evergreen Adult Day Care	HI	Adult Day Care Clinic/Center	$0	$8.9M

Deryll Ambrocio — Billing Profile & Reimbursement Data

Sign up for Deryll Ambrocio — Billing Profile & Reimbursement Data policy alerts

Deryll Ambrocio — Billing Profile & Reimbursement Data

Sign up for Deryll Ambrocio — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References